Neutrophils and acute lung injury

Critical Care Medicine

Volumn 31, Issue 4 SUPPL., 2003, Pages

  Abraham, Edward ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute lung injury; Akt; Neutrophils; Nuclear factor B; p38

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; SYNAPTOPHYSIN;

CONFERENCE PAPER; DISEASE SEVERITY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG FUNCTION; LUNG INJURY; MEDLINE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0037394676     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000057843.47705.e8     Document Type: Conference Paper

References (56)

1. Ognibene FP, Martin SE, Parker MM, et al: Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 1986; 315:547-551
2. Azoulay E, Darmon M, Delclaux C, et al: Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 2002; 30:781-786
3. Hierholzer C, Harbrecht B, Menezes JM, et al: Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998; 187:917-928
4. Abraham E, Bursten S, Shenkar R, et al: Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury following hemorrhage. J Exp Med 1995; 181:569-575
5. Terada LS, Dormish JJ, Shanley PF, et al: Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 1992; 263:L394-L401
6. Nill M, Oberyszyn TM, Ross MS, et al: Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. J Leukoc Biol 1995; 58:563-574
7. Parsey MV, Tuder R, Abraham E: Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. J Immunol 1998; 160:1007-1013
8. Abraham E, Kaneko DJ, Shenkar R: Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 1999; 276:L1-L8
9. Shenkar R, Abraham E: Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-κB, and cyclic AMP response element binding protein. J Immunol 1999; 163:954-962
10. Laffon M, Lu LN, Modelska K, et al: α-adrenergic blockade restores normal fluid transport capacity of alveolar epithelium after hemorrhagic shock. Am J Physiol 1999; 277:L760-L768
11. Heflin AC Jr, Brigham KL: Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 1981; 68:1253-1260
12. Till GO, Johnson KT, Kunkel R, et al: Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen intermediates. J Clin Invest 1982; 69:1126-1135
13. Abraham E, Carmody A, Shenkar R, et al: Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000; 279:L1137-L1145
14. Parsey MV, Tuder R, Abraham E: Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. J Immunol 1998; 160:1007-1013
15. Pugin J, Ricou B, Steinberg KP, et al: Proinflammatory activity in bronchoalveolar larage fluids from patients with ARDS, a prominent role for interleukfn-1. Am J Respir Crit Care Med 1996; 153:1850-1856
16. Abraham E: NF-κB activation. Crit Care Med 2000; 28:N100-N104
17. Baeuerle PA, Baltimore D: NF-κB: Ten years after. Cell 1996; 87:13-20
18. Foo SY, Nolan GP: NF-κB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 1999; 15:229-235
19. May MJ, Ghosh S: Signal transduction through NF-κB. Immunol Today 1998; 19:80-88
20. Ghosh S, May MJ, Kopp EB: NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-260
21. Senftleben U, Karin M: The IKK/NF-κB pathway. Crit Care Med 2002; 30(Suppl 1):S18-S26
22. Tak PP, Firestein GS: NF-κB: A key role in inflammatory diseases. J Clin Invest 2001; 107:7-11
23. Zhang G, Ghosh S: Toll-like receptor-mediated NF-κB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107:13-19
24. Birbach A, Gold P, Binder BR, et al: Signaling molecules of the NF-κB pathway shuttle constitutively between cytoplasm and nucleus. J Biol Chem 2002; 277:10842-10851
25. Blackwell TS, Blackwell TR, Holden EP, et al: In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol 1996; 157:1630-1637
26. Liu SF, Ye X, Malik AB: In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997; 159:3976-3983
27. Rameh LE, Cantley LC: The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 1999; 274:8347-8350
28. Wymann MP, Sozzani S, Altruda F, et al: Lipids on the move: Phosphoinositide 3-kinases in leukocyte function. Immunol Today 2000; 21:260-264
29. Datta SR, Brunet A, Greenberg ME: Cellular survival: A play in three AKTs. Genet Dev 1999; 13:2905-2927
30. Kandel ES, Hay N: The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999; 253:210-229
31. Toker A, Newton AC: Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J Biol Chem 2000; 275:8271-8274
32. Khwaja A: Akt is more than just a Bad kinase. Nature 1999; 401:33-34
33. Coffer PJ, Geijsen N, M'rabet L, et al: Comparison of the roles of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J 1998; 329:121-130
34. Liu Q, Sasaki T, Kozieradzki I, et al: SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 1999; 13:786-791
35. Ozes ON, Mayo LD, Gustin JA, et al: NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 401:82-85
36. Kane LP, Shapiro VS, Stokoe D, et al: Induction of NF-κB by the Akt/PKB kinase. Curr Biol 1999; 9:601-604
37. Yum H-K, Arcaroli J, Kupfner J, et al: Involvement of PI3-K in neutrophil activation and the development of acute lung injury. J Immunol 2001; 167:6601-6608
38. Sasaki T, Irie-Sasaki J, Jones RG, et al: Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 2000; 287:1040-1046
39. Li Z, Jiang H, Xie W, et al: Role of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 2000; 287:1046-1049
40. Hirsch E, Katanaev VL, Garlanda C, et al: Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 2000; 287:1049-1053
41. Madrid LV, Wang CY, Guttridge DC, et al: Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 2000; 20:1626-1638
42. L levels in vivo. J Exp Med 2000; 191:1721-1734
43. Romashkova JA, Makarov SS: NF κB is a target of Akt in anti-apoptotic PDGF signalling. Nature 1999; 401:86-90
44. Ardeshna KM, Pizzey AR, Devereux S. et al: The P13 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic ceils. Blood 2000; 96:1039-1046
45. Pugazhenthi S, Nesterova A, Sable C, et al: Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 2000; 275:10761-10766
46. Wang JM, Chao JR, Chen W, et al: The anti-apoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 1999; 19:6195-6206
47. Ward C, Chilvers ER, Lawson MF, et al: NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999; 274:4309-4318
48. Yang K-Y, Arcaroli J, Kupfner J, et al: Involvement of phosphatidylinositol 3-kinase γ in neutrophil apoptosis. Cell Signal 2002; 15:225-233
49. Nick JA, Avdi NJ, Young SK, et al: Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 1999; 103:851-858
50. Underwood DC, Osborn RR, Bochnowicz S, et al: SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 2000; 279:L895-L902
51. Detmers PA, Zhou D, Polizzi E, et al: Role of stress-activated mitogen-activated protein kinase (p38) in β-2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. J Immunol 1998; 161:1921-1929
52. Carter AB, Knudtson KL, Monick MM, et al: The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 1999; 274:30858-30863
53. Nick JA, Young SK, Brown KK, et al: Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 2000; 164:2151-2159
54. Arcaroli J, Yum HK, Kupfer J, et al: Role of p38 MAP kinase in the development of acute lung injury. Clin Immunol 2001; 101:211-219
55. Badger AM, Bradbeer JN, Votta B, et al: Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 1996; 279:1453-1461
56. Nick JA, Young SK, Arndt PG, et al: Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J Immunol 2002; 169:5260-5269